Glucose Clamp Techniques for Advancing the Development of Diabetes Type I and Type II Therapeutic Agents


24th March, 2010

11:00 AM - 12.30 PM EST / 8:00 AM - 9.30 AM PT / 4:00 PM - 5.30PM GMT

Introduction to the Glucose Clamp Model

  • Clamp procedure development: historical review
  • Operational considerations and points of reference
  • Types of clamps & Applications
  • Documented regulatory authority and industry recognition of the clamp procedure

Use of Glucose Clamping and Stable Isotopes to Understand Glucose Production and Utilization in Human Subjects

  • When to incorporate clamps in the development process
  • Consideration in protocol design (insulin infusions, insulin priming etc.)
  • The use of isotopes in clamps and examples of isotope data analysis

The Hyperglycemic Clamp as a Method for Assessing Beta-Cell Sensitivity and Insulin Resistance
Benefit of hyperglycemic clamp as opposed to other methods of assessing beta-cell response

  • Hyperglycemic clamp variations and their applications
  • Methods of testing pancreatic reserve
  • Infusion of native proteins

Expert Panelists:

Dariush Elahi, M.D.
Johns Hopkins Medical School Department of Surgery & Harvard Medical School Department of Medicine

Michael R. Rickels, M.D.
Assistant Professor of Medicine
Division of Endocrinology, Diabetes & Metabolism. University of Pennsylvania School of Medicine
 
Cyril Clarke, BSc, MBBS, MFPM.
Vice President Translational Medicine, ICON Development Solutions

Clayton Dehn
Manager of Glucose Clamp Services
ICON Development Solutions

To Register please click here